Addex to Present at the H.C. Wainwright 23rd Annual Global Investment Conference

Addex to Present at the Swiss Biotech Day

Addex Reports 2021 Half Year and Second Quarter Financial Results and Provides Corporate Update

Addex Appoints Seasoned Pharma Drug Researcher Mikhail Kalinichev as Head of Translational Science

Addex Therapeutics to Release Half-Year 2021 Financial Results and Host Conference Call on August 5, 2021

Addex and Indivior Extend Research Collaboration on GABAB Positive Allosteric Modulators - Indivior Commits $4 Million of New Funding

Addex Therapeutics to Present at Access to Giving Virtual Conference on July 14, 2021

Addex, Stanford University and University of Copenhagen Publish mGlu2 Structure in Nature Using Addex Allosteric Modulators

Addex Establishes At-The-Market ADS Equity Sale Program

Addex Therapeutics Initiates Pivotal Phase 2b/3 Study with Dipraglurant for Dyskinesia Associated with Parkinson’s Disease